Stephen J Carter
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (11)
Year:
2026
Year:
2026
Year:
2026
Purpose : To examine potential sex differences in recovery following strenuous aerobic exercise and to assess associations between recovery and symptoms in female exercisers. Methods : Nine recreationally active/trained males (peak aerobic power [Peak AP ] = 4.4 [0.7] W/kg) and 11 females (Peak AP = 4.3 [0.5] W/kg) completed an 8-km cycling time trial (8 kmTT) followed by a time to exhaustion (TTE) glycogen-depletion workout with 2-minute intervals at 90%, 80%, and 70% Peak AP separated by 2-minutes recovery at 50% Peak AP on 3 occasions. Recovery was quantified as finishing time of an 8 kmTT performed 24 hours following each session, adjusted for day 1. Females completed a Menstrual Symptom Index assessing the frequency and severity of 18 commonly experienced symptoms preexercise and postexercise. Results : After adjusting for day 1, a main effect ( P = .024) was observed with females completing the 8 kmTT 18 seconds (3–33 s) slower than males on day 2. Between-sex differences were not observed during the total TTE ( P = .990), TTE at 70% Peak AP ( P = .571), or 80% Peak AP ( P = .421). However, males exhibited a superior TTE at 90% Peak AP , ( P = .018). Menstrual Symptom Index scores preexercise ( r = .77 [.32–.94], P = .005) and postexercise ( r = .66 [.11–.90], P = .026) were associated with 8 kmTT recovery. Conclusion : Female exercisers may experience a differential recovery compared with males 24 hours after a strenuous bout of aerobic exercise. Such differences may be related to menstrual symptom burden.
Year:
2026
Year:
2025
Background Physical activity reduces morbidity and mortality risk in cancer survivors, but a meaningful proportion of this vulnerable population are physically inactive. Targeted interventions can help cancer survivors adopt a more active lifestyle, but the efficacy of these interventions must be rigorously evaluated in randomized controlled intervention trials. A major barrier to such trials involves the difficulty in obtaining unbiased estimates of physical activity in free-living conditions. Methods We conducted a randomized controlled trial of a 3-month intervention designed to increase physical activity vs. usual care in breast cancer survivors (n = 316). The primary outcome was change in physical activity as estimated by hip-worn accelerometer (MTI/Actigraph, models GT1M and GT3X). The trial included a sub-study (n = 106) wherein unbiased measures of total energy expenditure (doubly labeled water), and resting energy expenditure (indirect calorimetry) were collected. A linear mixed measurement error model characterized the structure of measurement error in accelerometry-estimated physical activity energy expenditure (PAEE), and corrected for bias in the estimated intervention effect due to measurement error. Results Bias in the accelerometer estimates was related to true PAEE ( p < 0.001) and baseline body mass index ( p < 0.001) but was not related to age ( p = 0.13). After correcting for measurement error, the estimated intervention effect at 3 months (change from baseline in PAEE in the intervention arm minus change in the control arm) was 77 kcal/day (95% confidence interval (CI) = 31–125), compared to 48 kcal/day (95% CI = 22–75) when measurement error was ignored. These results indicate a 20% (21%) increase in PAEE kcal x d −1 (kcal x kg −1 × d −1 ) at month 3 relative to baseline for the corrected model vs. 14% (15%) for the uncorrected model. There was no evidence that measurement error in accelerometry-estimated PAEE was differential (differed by treatment arm) in the trial (p = 0.86). Conclusions Measurement error in accelerometer-estimated PAEE can attenuate the effect size related to intervention effects in randomized controlled trials of physical activity interventions. Sub-studies that collect unbiased measures of PAEE can be used to correct for this short-coming. Trial registration ClinicalTrials.gov; NCT00929617; registered 06/26/2009; https://clinicaltrials.gov/study/NCT00929617
Year:
2025
Year:
2025
Though exercise training represents the principal strategy to combat age-related decline, the attendant effects of menopause weaken aspects of exercise adaptation compared with premenopausal women and age-matched men. Here we provide important initial evidence that preworkout (i.e., an acute dose before training) beetroot juice coupled with an 8-wk, circuit-based exercise training intervention may uniquely benefit late postmenopausal women by enhancing indices of physical function including aerobic capacity and recovery.
Year:
2024
Introduction Breast cancer survivors have an increased risk for chronic fatigue and altered gut microbiota composition, both with negative health and quality of life affects. Exercise modestly improves fatigue and is linked to gut microbial diversity and production of beneficial metabolites. Studies suggest that gut microbiota composition is a potential mechanism underlying fatigue response to exercise. Randomised controlled trials testing the effects of exercise on the gut microbiome are limited and there is a scarcity of findings specific to breast cancer survivors. The objective of this study is to determine if fitness-related modifications to gut microbiota occur and, if so, mediate the effects of aerobic exercise on fatigue response. Methods and analysis The research is a randomised controlled trial among breast cancer survivors aged 18–74 with fatigue. The primary aim is to determine the effects of aerobic exercise training compared with an attention control on gut microbiota composition. The secondary study aims are to test if exercise training (1) affects the gut microbiota composition directly and/or indirectly through inflammation (serum cytokines), autonomic nervous system (heart rate variability) or hypothalamic-pituitary-adrenal axis mediators (hair cortisol assays), and (2) effects on fatigue are direct and/or indirect through changes in the gut microbiota composition. All participants receive a standardised controlled diet. Assessments occur at baseline, 5 weeks, 10 weeks and 15 weeks (5 weeks post intervention completion). Faecal samples collect the gut microbiome and 16S gene sequencing will identify the microbiome. Fatigue is measured by a 13-item multidimensional fatigue scale. Ethics and dissemination The University of Alabama at Birmingham Institutional Review Board (IRB) approved this study on 15 May 2019, UAB IRB#30000320. A Data and Safety Monitoring Board convenes annually or more often if indicated. Findings will be disseminated in peer-reviewed journals and conference presentations. Trial registration number ClinicalTrials.gov, NCT04088708 .
Year:
2024
Year:
2024
Year:
2023
Collaborators (9)
Robert Oster
Professor
The University of Alabama
Andrew R. Coggan
Associate Professor
Indiana University-Purdue University Indianapolis
Hsien-Chang Lin
Chair and Professor
San Diego State University
Zachary Schlader
Associate Professor
Indiana University Bloomington
Laura Q. Rogers
The University of Alabama
Elliot Lefkowitz
Full Professor (with tenure)
The University of Alabama
Timothy D. Mickleborough
Indiana State University
Nianjun Liu
Professor
Indiana University
Marwah Abdalla
Associate Professor of Medicine
Columbia University
Make your next move.
Prepare your application
Review drafts before you send them.